Clinical trials
Thrombosis clinical trials
Below are recruiting thrombosis clinical trials, each written for real people, not researchers. We’re tracking 180 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04664933Recruiting
Study to protect the brain during clot-removal stroke treatment
This trial tests a brain-protective approach given through an artery during treatment for an acute ischemic stroke when clot removal (endovascular therapy) is planned. It may help reduce brain injury related to the stroke and procedure.
ShenyangAges 18 years+ - NCT04731558RecruitingPhase 4
Blood clot prevention before versus after liver surgery
This study compares two approaches to preventing blood clots around the time of liver surgery. If you’re having planned liver surgery, it may help doctors choose the safest timing and method for clot prevention.
HelsinkiAges 18 years+ - NCT04754659Recruiting
Checking kidney function after EVAR stent graft for aneurysm
This study looks at how a stent graft treatment for an abdominal aortic aneurysm affects kidney function over time. It may help doctors choose the safest approach for people whose aneurysm is treated with a procedure called EVAR.
Gothenburg, VastraGotalandAges 18–90 - NCT04924322RecruitingPhase 2/Phase 3
Early blood clot prevention after certain central line insertions
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
Birmingham, AlabamaAges Up to 17 years - NCT04988685Recruiting
Heart artery balloon treatment registry study for adults
This study follows adults with blocked heart arteries who are treated using a special type of balloon (drug-coated balloon) during a procedure. It aims to track real-world outcomes to better understand how well this treatment works for people with new blockages or previously treated vessel narrowing.
Lucerne, Canton of LucerneAges 18 years+ - NCT05098769Recruiting
Prediction tool for risks after acute pulmonary embolism scans
This trial studies a tool that uses CT scan results and heart blood tests to predict the chance of serious outcomes after an acute pulmonary embolism (a blood clot in the lung). It may help doctors identify higher-risk patients sooner.
Shenyang, LiaoningAges 18 years+ - NCT05245877RecruitingPhase 4
Preventing blood clots before and after pancreatic surgery
This study compares two approaches to preventing blood clots around the time of pancreatic surgery. It may help lower the risk of dangerous clotting events after surgery, especially for people who are high risk.
TorontoAges 18–120 - NCT05476913Recruiting
Preventing blood clots after stroke with a leg device
This study checks whether using a special device on the legs can help prevent dangerous blood clots after an acute stroke. You may be eligible if you recently had a stroke and you’re not able to get up and walk to the toilet without help.
Bury St Edmunds, SuffolkAges 18 years+ - NCT05482269Recruiting
Using CT scans to predict outcomes after lung blood clots
This trial uses an artificial intelligence (AI) system to read CT scan images of the lungs and predict outcomes after a pulmonary embolism (a blood clot in the lung). It may help doctors identify who is at higher risk, so treatment decisions can be faster and more accurate.
Shenyang, LiaoningAges 18 years+ - NCT05568966Recruiting
Blood sample collection for new diagnostic tests
This study collects small blood samples to help test and improve new diagnostic devices. You may be eligible if you’re an adult with certain symptoms that match one of several health “groups,” and if you can consent and read English.
Airdrie, ScotlandAges 18 years+ - NCT05628948Recruiting
Donate blood for a heart and metabolism research biobank
This study builds a “biobank,” which is a collection of blood and related samples, to support future research on heart and metabolic (sugar/body-fat) conditions. It may help researchers better understand these diseases and improve future prevention and treatments.
Cleveland, OhioAges 18 years+ - NCT05636748Recruiting
Study how blood clots affect stroke, using special scans
This study looks at how blood clots form and contribute to an acute ischemic (clot-related) stroke. It uses PET-CT scanning to better understand the process and may help improve how future stroke treatments are targeted.
EdinburghAges 18 years+ - NCT05646394Recruiting
Registry for blood-clot prevention plans in arterial antiphospholipid syndrome
This study keeps a registry to follow people with antiphospholipid syndrome (APS) who have had arterial blood clots (like stroke). It collects information about the treatment approach your clinician chooses to see how different antithrombotic regimens may perform and be tolerated.
Buenos Aires, Buenos Aires F.D.Ages 18 years+ - NCT05663281Recruiting
Imaging treatment plan for blocked brain or neck arteries
This study uses special MRI “vessel wall” imaging to better understand blocked arteries in the brain or neck, confirmed on a scan. It aims to help analyze imaging findings to guide treatment decisions and reduce problems from artery blockage.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05710705Recruiting
Bioimpedance monitoring in belly-flap breast reconstruction
This study tests a method called bioimpedance to monitor blood flow in the transplanted belly tissue during breast reconstruction surgery. It may help doctors know when the blood supply is stable, which could lead to safer recovery.
AmiensAges 18 years+ - NCT05711173Recruiting
Study blood clot triggers and immune cell changes in clot patients
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
BordeauxAges 6–50 - NCT05758662Recruiting
PET-CT and heart ultrasound study valve changes after TAVI
This study looks at whether certain valve blood clots (called “subclinical leaflet thrombosis”) and different valve types are linked to valve aging over time. It uses a special PET-CT scan and an echocardiogram to measure changes in the heart valve about five years after TAVI.
CopenhagenAges 18 years+ - NCT05782556Recruiting
Freiburg TIPS Registry for portal hypertension patients
This is a registry study that collects information from people who need a procedure called TIPS for portal hypertension. It may help doctors better understand outcomes and care for both cirrhotic and non-cirrhotic causes of portal hypertension.
Freiburg im BreisgauAges 18–100 - NCT05789108Recruiting
Study of first leg blood clot and long-term effects
This study looks at people having their first blood clot in the leg and how it can affect them long-term. It may help doctors better predict complications and improve follow-up care after an emergency visit.
Hvidovre, CopenhagenAges 18 years+ - NCT05853796Recruiting
Studying stroke warning signs in young adults
This observational study follows people ages 18–50 who had a first TIA (“mini-stroke”) or an acute ischemic stroke to better understand what happens after the event. It may help improve future care by tracking symptoms, imaging findings, and recovery over time.
Nijmegen, GelderlandAges 18–50 - NCT05864638Recruiting
Registry study of clot-removal treatment for acute stroke
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
ShanghaiAges Any age - NCT05881798Recruiting
Vena cava filter data study for specific filter type
This study checks outcomes and safety using real-world health data from people who received a specific type of vena cava filter. It may help improve future care by understanding how these devices perform after placement.
Los Angeles, CaliforniaAges 18 years+ - NCT05882370RecruitingPhase 2
Immunotherapy plus TIPS for liver cancer with blocked portal vein
This study tests whether adding the immunotherapy drug cadonilimab (and a related treatment plan) plus TIPS can help people with advanced liver cancer that has a tumor clot causing portal vein pressure problems. It aims to improve disease control while managing the circulation pressure in the liver.
Guangzhou, GuangdongAges 18–75 - NCT05938530Recruiting
Sirolimus balloon vs stent graft for blocked arm dialysis access
This trial compares two ways to reopen a blocked “dialysis access” vessel in the upper arm after a clot is treated. It may help keep blood flowing in the access longer and reduce the chance of re-blockage.
SingaporeAges 21–85
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for thrombosis?
- Yes. Clin2 currently lists 180 recruiting thrombosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a thrombosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a thrombosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.